Biolidics lands 5-year licensing deal to develop COVID-19 test kits
Category: #health  | By Nikita Chaurasia  | Date: 2020-07-16 |
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Biolidics lands 5-year licensing deal to develop COVID-19 test kits

Biolidics, a precision medicine medical technology company, headquartered in Singapore, on July 9 inked an agreement with the commercialization arm of the Agency for Science, Technology and Research (A*Star), Accelerate Technologies, to use the agency’s COVID-19 viral spike detection technology, cites sources.

Reportedly, under the agreement, Accelerate Technologies is granting non-exclusive worldwide rights to Biolidics for using the technology for diagnostic application and to advance it and market new serology tests that utilize the technology.

Previously, in April, the company obtained authorization for the use of test kits in the Philippines, European Union, and US, and also partnered with the scandal-hit Aytu for distribution of its kits. In the following month, the company appointed Clearbridge Health as a distributor in the Philippines, Myanmar, Indonesia, and Vietnam.

In June, the company reportedly called off the sale of its test kits in the US due to high competition. At the same time, it also announced development of a new test kit in collaboration with Aytu.

With so many variables, the Catalisted-firm is under the close watch of SGX (The Singapore Exchange). Biolidics was inquired on its late announcement as the deal was closed few days ago, whether its sponsor was aware and consulted, and was asked to disclose the advice the sponsor gave as well as its trading halt & announcement timings, cites sources with the knowledge of the matter.

Prior to the agreement with Accelerate Technologies, earlier this month, the company declared its five-year agreement with China's LC-Bio for developing cancer-diagnostic solutions.

The company’s share spiked by 29.3 percent on Monday before its trading halt at 12:19 pm. The A*Star announcement was made at 10:46 pm the following day, before lifting the halt on Wednesday morning before the market’s opening bell.

 

Source: https://www.straitstimes.com/business/companies-markets/biolidics-signs-5-year-licence-with-astar-arm-eyes-development-of-new

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

McKinsey commences job cuts focused on non-client serving teams

McKinsey commences job cuts focused on non-client serving teams

By Nikita Chaurasia

McKinsey and Co. a consulting giant entity has decided to start cutting jobs in one of the biggest rounds of layoffs for the company. This is likely to eliminate the jobs of about 2000 employees from work. The layoffs will be focused on support st...

Fintech firm PayPal to shed around 2000 staff as global economy plummets

Fintech firm PayPal to shed around 2000 staff as global economy plummets

By Nikita Chaurasia

PayPal, the U.S.-based fintech giant, has reportedly announced that it will cut nearly 2000 jobs, approximately 7% of its workforce, as it turns the latest prominent tech company to shed staff in a bid to cut costs. The online payments provider cl...

EasyJet sees a rise in bookings as customers plan their next vacations

EasyJet sees a rise in bookings as customers plan their next vacations

By Nikita Chaurasia

British multinational low-cost airline group, EasyJet, has reported a record surge in bookings for the month of January as people prioritized their travel plans for the coming year. The news comes as airlines world over start to show signs that they&...